Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma
Authors: Rosiñol, Laura1; Carrió, Ana2; Bladé, Joan1; Queralt, Rosa2; Aymerich, Marta2; Cibeira, MaTeresa1; Esteve, Jordi1; Rozman, Maria2; Campo, Elías2; Montserrat, Emili1
Source: British Journal of Haematology, Volume 130, Number 5, September 2005 , pp. 729-732(4)
Publisher: Blackwell Publishing
Abstract:
Summary Two variants of smoldering multiple myeloma (SMM) have been recognised: (i) an evolving type, characterised by a progressive increase in the M-protein size and short time to progression to overt multiple myeloma (MM) and (ii) a non-evolving type, with a long-lasting, stable M-protein and longer time to progression. Comparative genomic hybridisation (CGH) analyses in both subtypes of SMM (seven evolving and eight non-evolving SMM) were performed. Evolving SMM showed cytogenetic changes consistent with those found in de novo symptomatic MM (1q gains, chromosome 13 deletions) while the non-evolving variant showed no 1q gains and deletions were uncommon.Keywords: smoldering multiple myeloma; comparative genomic hybridisation; multiple myeloma; prognosis; transformation
Document Type: Research article
DOI: 10.1111/j.1365-2141.2005.05673.x
Affiliations: 1: Haematology Department, Institute of Haematology and Oncology, Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona 2: Haematopathology Department, Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain

Click here for Page Help